JetBlue Airways, VOXX International And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Portfolio Pulse from Lisa Levin
Several stocks are recording losses in today's pre-market trading session. These include Viridian Therapeutics, VOXX International, Iovance Biotherapeutics, Equitrans Midstream, Allego, Nayax, JetBlue Airways, Novo Nordisk, and Alcoa Corporation. The reasons for the declines vary from disappointing quarterly results to downgrades by research firms.
July 11, 2023 | 11:21 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Alcoa shares fell 2.3% after Wolfe Research downgraded the stock from Peer Perform to Underperform.
The downgrade by Wolfe Research has directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Allego shares declined 4.1% in pre-market trading.
The reason for the stock price decline is not specified in the news.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Equitrans Midstream shares fell 5.6% in pre-market trading.
The reason for the stock price decline is not specified in the news.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Iovance Biotherapeutics shares tumbled 12.5% as the company priced its underwritten public offering of shares.
The pricing of the company's public offering has directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
JetBlue Airways shares declined 3% after Evercore ISI Group downgraded the stock from In-Line to Underperform.
The downgrade by Evercore ISI Group has directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Novo Nordisk shares declined 2.6% after Ginkgo Bioworks reported completion of pilot phase of partnership with the company.
The completion of the pilot phase of the partnership with Ginkgo Bioworks has directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Nayax shares fell 3.3% in pre-market trading.
The reason for the stock price decline is not specified in the news.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
VOXX International shares declined 13.8% due to downbeat results for its third quarter.
The company's poor Q3 results have directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Viridian Therapeutics shares dipped 14.4% after announcing data from ongoing Phase 1/2 trial.
The announcement of the trial data has directly impacted the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100